• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Roslin Foundation

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Axol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease modelsAxol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease models
    Axol Bioscience
    13 Jan 2026

    Axol Bioscience announces £2m in funding led by BroadOak Capital Partners to supply stem cell-derived disease models

    Axol Bioscience supplies stem cell-derived disease models to researchers, supporting drug discovery with more human-relevant biology.

Roslin Foundation
    • Life Sciences
  • 1(12 months)
  • roslinfoundation.uk
  • Update Information

More venture news

  • Callosum unlocks £7.5m in funding led by Plural to challenge single-chip AI systems
    Callosum
    26 Feb 2026

    Callosum unlocks £7.5m in funding led by Plural to challenge single-chip AI systems

    EquityAI
  • Bindbridge secures £2.8m in funding from Speedinvest and Nucleus Capital to boost agricultural outputs with crop protection technology
    Bindbridge
    3 Mar 2026

    Bindbridge secures £2.8m in funding from Speedinvest and Nucleus Capital to boost agricultural outputs with crop protection technology

    EquityAgriculture
  • Thema raises £4.6m in funding led by Stride.vc to provide PE investors with infrastructure for portfolio expansion
    Thema
    24 Feb 2026

    Thema raises £4.6m in funding led by Stride.vc to provide PE investors with infrastructure for portfolio expansion

    EquityFintech

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn